The ROE as of December 2024 (TTM) for Defence Therapeutics Inc. (DTCFF) is 377.40%

According to Defence Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is 377.40%. This represents a change of 219.42% compared to the average of 118.15% of the last 4 quarters.

Defence Therapeutics Inc. (DTCFF) Historical ROE (quarterly & annually)

How has DTCFF ROE performed in the past?

The mean historical ROE of Defence Therapeutics Inc. over the last ten years is 728.79%. The current 377.40% ROE has changed -48.22% with respect to the historical average. Over the past ten years (40 quarters), DTCFF's ROE was at its highest in in the September 2019 quarter at 8.83%. The ROE was at its lowest in in the March 2022 quarter at -111.91%.

Defence Therapeutics Inc. (DTCFF) ROE by Quarter and Year

Discovering the peaks and valleys of Defence Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Defence Therapeutics Inc. (DTCFF) Average ROE

How has DTCFF ROE performed in the past?

The current ROE of Defence Therapeutics Inc. (DTCFF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Defence Therapeutics Inc. (DTCFF) ROE vs. Peers

How is DTCFF’s ROE compared to its peers?

Defence Therapeutics Inc.’s ROE is less than Sino Biopharmaceutical Limited (11.52%), less than Institute of Biomedical Research Corp. (131.12%), greater than Aileron Therapeutics, Inc. (-46.89%), greater than Enlivex Therapeutics Ltd. (-67.57%), less than Panbela Therapeutics, Inc. (304.71%), greater than Lixte Biotechnology Holdings, Inc. (-149.08%), greater than Benitec Biopharma Inc. (-60.28%), greater than Cingulate Inc. (-113174.53%), greater than TRACON Pharmaceuticals, Inc. (-237.65%), greater than XOMA Corporation (-33.68%), greater than Fortress Biotech, Inc. (-240.30%), less than Checkpoint Therapeutics, Inc. (359.97%), less than ZIVO Bioscience, Inc. (618.61%), greater than Lumos Pharma, Inc. (-233.03%), less than Apellis Pharmaceuticals, Inc. (0%), greater than Terns Pharmaceuticals, Inc. (-103.92%), greater than Day One Biopharmaceuticals, Inc. (-32.76%), greater than Blueprint Medicines Corporation (-22.40%), greater than Cerevel Therapeutics Holdings, Inc. (-47.66%), greater than null (-98.94%),

Build a custom stock screener for Defence Therapeutics Inc. (DTCFF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Defence Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Defence Therapeutics Inc. (DTCFF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Defence Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.